This inventor holds 2 USPTO granted patents and 5 published patent applications. Top assignees: Sepracor, Inc., Other. Active years: 2007-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 322 
1 out of 834,601 Years Active: 2007-2014
Title: Paul McGlynn: Innovator in Pharmaceutical Patents
Introduction
Paul McGlynn is a notable inventor based in Marlborough, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of inhalation therapies. With a total of 2 patents, his work has had a meaningful impact on respiratory medicine.
Latest Patents
Among his latest patents is the Levalbuterol salt, specifically Levalbuterol L-tartrate, which affords crystals possessing properties desirable for use in a metered dose inhaler. This innovation is crucial for improving the delivery of medication to patients with respiratory conditions.
Career Highlights
Throughout his career, Paul has worked with Sepracor, Inc., a company known for its focus on respiratory therapies. His experience in this field has allowed him to develop innovative solutions that enhance patient care.
Collaborations
Paul has collaborated with notable professionals in the industry, including Craig Sturge and Roger P. Bakale. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Paul McGlynn's contributions to pharmaceutical innovations, particularly in inhalation therapies, highlight his role as a significant inventor in the field. His work continues to influence the development of effective treatments for respiratory conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile